Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
24.36
-1.29 (-5.03%)
At close: Jul 15, 2025, 4:00 PM
25.50
+1.14 (4.68%)
After-hours: Jul 15, 2025, 4:32 PM EDT
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $172.56 million as of July 15, 2025. Its market cap has increased by 1,245.50% in one year.
Market Cap
172.56M
Enterprise Value
132.10M
1-Year Change
1,245.50%
Ranking
Category
Stock Price
$24.36
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $172.56M, an increase of 312.98%. That is a compound annual growth rate of 37.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 180.92M | -27.82% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.95B |
| Johnson & Johnson | 376.33B |
| AbbVie | 337.78B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 272.34B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 230.41B |
| AstraZeneca | 218.74B |